Alnylam Pharmace. buy Citigroup Inc.
Start price
21.03.25
/
50%
€261.50
Target price
21.03.26
€323.45
Performance (%)
2.98%
End price
22.03.26
€269.30
Summary
This prediction ended on 22.03.26 with a price of €269.30. The BUY prediction by Citigroup_Inc_ finished with a performance of 2.98%. Citigroup_Inc_ has a follow-up prediction for Alnylam Pharmace. where he still thinks Alnylam Pharmace. is a Buy. Citigroup_Inc_ has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Alnylam Pharmace. | -3.390% | -3.390% | -0.409% |
| iShares Core DAX® | -3.640% | -8.784% | -0.694% |
| iShares Nasdaq 100 | -2.986% | -1.710% | 11.948% |
| iShares Nikkei 225® | -3.000% | -9.097% | 23.387% |
| iShares S&P 500 | -2.389% | -2.781% | 7.620% |
Comments by Citigroup_Inc_ for this prediction
In the thread Alnylam Pharmace. diskutieren
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its price target raised by analysts at Citigroup Inc. from $338.00 to $351.00. They now have a "buy" rating on the stock.
Ratings data for ALNY provided by MarketBeat
In the thread Trading Alnylam Pharmace.
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Citigroup_Inc_ for Alnylam Pharmace.
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€269.40
11.07.25
11.07.25
€346.03
11.07.26
11.07.26
-0.56%
24.03.26
24.03.26
Stopped prediction by Citigroup_Inc_ for Alnylam Pharmace.
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€384.10
02.09.25
02.09.25
€498.17
02.09.26
02.09.26
-30.25%
24.03.26
24.03.26
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€247.40
02.08.24
02.08.24
€313.41
02.08.25
02.08.25
38.64%
03.08.25
03.08.25
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€225.00
25.06.24
25.06.24
€271.50
25.06.25
25.06.25
23.51%
26.06.25
26.06.25
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€136.40
16.02.24
16.02.24
€210.72
16.02.25
16.02.25
80.65%
17.02.25
17.02.25